暂无数据
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
自选模拟交易
美股期权个股详情
BIB241220P95000
- 0.00
- 0.000.00%
延时15分钟行情交易中 11/22 09:30 (美东)
0.00最高价0.00最低价
0.00今开0.00昨收0张成交量0张未平仓合约数95.00行权价0.00成交额113.60%隐含波动率-68.53%溢价2024/12/20到期日38.63内在价值100合约乘数28天距到期日0.00时间价值100合约规模美式期权类型-0.9387Delta0.0081Gamma1.44杠杆倍数-0.0313Theta-0.0364Rho-1.35有效杠杆0.0187Vega
分时
- 5日
- 日K
暂无内容
新闻
生物科技领域的投降即将来临，以及一波上涨 - 派杰投资
为何递归成为人工智能和药物发现的首选
ProShares Ultra纳斯达克生物技术宣布季度分配$0.2648。
ProShares Ultra Nasdaq Biotechnology宣布季度分红
ProShares Ultra 纳斯达克生物技术公司宣布季度分销额为0.0383美元
私人顾问集团有限责任公司持有ProShares Ultra Nasdaq Biotechnology（纳斯达克股票代码：BIB）2.308亿美元的
根据其向美国证券交易委员会提交的最新文件，Private Advisor Group LLC在第四季度收购了ProShares Ultra Nasdaq Biotechnology（纳斯达克股票代码：BIB — 获取评级）的新股份。该公司
评论
已翻译
你对2024年生物科技板块持看好态度吗？欢迎在下方评论中分享和讨论。🥰 $SPDR标普生物科技ETF (XBI.US)$ $ProShares Ultra纳斯达克生物科 (BIB.US)$ $生物科技指数ETF-iShares (IBB.US)$
已翻译
6
1
$ProShares Ultra纳斯达克生物科 (BIB.US)$ was climbing 1.5%.
$SciSparc (SPRC.US)$ rallied Wednesday, climbing over 20%, after the Israeli pharmaceuticals company said the psychedelic-based MEAI drug candidate developed with Canadian collaborator Clearmind Medicine produced a significant decrease in coccaine craving in rats compared to those in a non-treated control group during pre-clinical testing.
$Glaukos (GKOS.US)$ gained 6% after We...
$SciSparc (SPRC.US)$ rallied Wednesday, climbing over 20%, after the Israeli pharmaceuticals company said the psychedelic-based MEAI drug candidate developed with Canadian collaborator Clearmind Medicine produced a significant decrease in coccaine craving in rats compared to those in a non-treated control group during pre-clinical testing.
$Glaukos (GKOS.US)$ gained 6% after We...
3
阅读更多